Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 3 Expression and Its Correlation with Prognosis and Growth of Serous Ovarian Cancer: Correlation of DYRK3 with Ovarian Cancer Survival

<table class="figure-group"><tr class="fig-image" id="a"><td><object data="https://static.hindawi.com/articles/ijg/volume-2024/6683202/figures/6683202.fig.001a.svgz" name="6683202.fig.001a" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(a) </b>High immunoreactivity of DYRK3</td></tr><tr class="fig-image" id="b"><td><object data="https://static.hindawi.com/articles/ijg/volume-2024/6683202/figures/6683202.fig.001b.svgz" name="6683202.fig.001b" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(b) </b>Low immunoreactivity of DYRK3</td></tr></table>

<div>DYRK3 protein expression in ovarian cancer tissues. (a) Immunohistochemistry staining depicting representative high DYRK3 protein expression in ovarian cancer tissues. The immunoreactivity is prominently localized in the nucleus, with additional cytosol staining. (b) Representative low DYRK3 protein expression in ovarian cancer tissues. Magnification: 400x.</div>

International Journal of Genomics

fig1

Figure 1

Figure 1: Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 3 Expression and Its Correlation with Prognosis and Growth of Serous Ovarian Cancer: Correlation of DYRK3 with Ovarian Cancer Survival 

Figure 1 | Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 3 Expression and Its Correlation with Prognosis and Growth of Serous Ovarian Cancer: Correlation of DYRK3 with Ovarian Cancer Survival 